
Chfr inactivation is not associated to chromosomal instability in colon cancers
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

ABSTRACT Numerous observations suggest that chromosome instability is caused by mitotic abnormalities such as errors in the partitioning of chromosomes. _Chfr_ was recently defined as a
central component of a new mitotic checkpoint that delays chromosome condensation in response to mitotic stress. _Chfr_ was shown to be frequently inactivated in several human neoplasms,
including colon, lung and esophageal cancers. To test whether _Chfr_ inactivation may lead or participate to chromosomal instability (CIN), we analysed the genetic and epigenetic status of
the gene in a large panel of primary colon and breast cancers, as well as in colon and breast cancer cell lines displaying either a microsatellite instability or a CIN. Our results confirm
that _Chfr_ is frequently inactivated in colon cancers, through a mechanism of hypermethylation of the promoter sequences. In contrast, the loss of _Chfr_ expression appears to be a rare
event in breast cancers. Furthermore, our data demonstrate that _Chfr_ inactivation is not associated with CIN in these frequent types of human cancers. Access through your institution Buy
or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 50 print issues and
online access $259.00 per year only $5.18 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes
which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY
OTHERS CHROMOSOMAL INSTABILITY AS A DRIVER OF CANCER PROGRESSION Article 29 July 2024 A PAN-CANCER COMPENDIUM OF CHROMOSOMAL INSTABILITY Article 15 June 2022 THE TWO SIDES OF CHROMOSOMAL
INSTABILITY: DRIVERS AND BRAKES IN CANCER Article Open access 29 March 2024 REFERENCES * Ahuja N, Mohan AL, Li Q, Stolker JM, Herman JG, Hamilton SR, Baylin SB and Issa JP . (1997). _Cancer
Res._, 57, 3370–3374. * Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, Vogelstein B and Lengauer C . (2002). _Cancer Res._, 62, 1129–1133. * Cahill DP, Lengauer C, Yu J,
Riggins GJ, Willson JK, Markowitz SD, Kinzler KW and Vogelstein B . (1998). _Nature_, 392, 300–303. * Corn PG, Summers MK, Fogt F, Virmani AK, Gazdar AF, Halazonetis TD and El-Deiry WS .
(2003). _Carcinogenesis_, 24, 47–51. * Doxsey S . (2002). _Mol. Cell_, 10, 439–440. * Duval A and Hamelin R . (2002). _Ann. Genet._, 45, 71–75. * Forozan F, Mahlamaki EH, Monni O, Chen Y,
Veldman R, Jiang Y, Gooden GC, Ethier SP, Kallioniemi A and Kallioniemi OP . (2000). _Cancer Res._, 60, 4519–4525. * Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P and Hamelin R .
(2001). _Oncogene_, 20, 5025–5032. * Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G and Ried T . (2000). _Genes Chromosomes Cancer_, 27, 183–190. * Gioanni
J, Le Francois D, Zanghellini E, Mazeau C, Ettore F, Lambert JC, Schneider M and Dutrillaux B . (1990). _Br. J. Cancer_, 62, 8–13. * Imai Y, Shiratori Y, Kato N, Inoue T and Omata M .
(1999). _Jpn. J. Cancer Res._, 90, 837–840. * Jackson AL and Loeb LA . (1998). _Semin. Cancer Biol._, 8, 421–429. * Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith
HS, Pinkel D, Gray JW and Waldman FM . (1994). _Proc. Natl. Acad. Sci. USA_, 91, 2156–2160. * Kang D, Chen J, Wong J and Fang G . (2002). _J. Cell Biol._, 156, 249–259. * Kytola S,
Rummukainen J, Nordgren A, Karhu R, Farnebo F, Isola J and Larsson C . (2000). _Genes Chromosomes Cancer_, 28, 308–317. * Lengauer C, Kinzler KW and Vogelstein B . (1998). _Nature_, 396,
643–649. * Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C and Salisbury JL . (2002). _Proc. Natl. Acad. Sci. USA_, 99, 1978–1983. * Loeb LA
and Christians FC . (1996). _Mutat. Res._, 350, 279–286. * Luker KE, Pica CM, Schreiber RD and Piwnica-Worms D . (2001). Overexpression of IRF9 confers resistance to antimicrotubule agents
in breast cancer cells. _Cancer Res._, 61, 6540–6547. CAS PubMed Google Scholar * Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T, Fujii Y and Takahashi T . (2002).
_Oncogene_, 21, 2328–2333. * Paulovich AG, Toczyski DP and Hartwell LH . (1997). _Cell_, 88, 315–321. * Rummukainen J, Kytola S, Karhu R, Farnebo F, Larsson C and Isola JJ . (2001). _Cancer
Genet. Cytogenet._, 126, 1–7. * Sato M, Sekido Y, Horio Y, Takahashi M, Saito H, Minna JD, Shimokata K and Hasegawa Y . (2000). _Jpn. J. Cancer Res._, 91, 504–509. * Scolnick DM and
Halazonetis TD . (2000). _Nature_, 406, 430–435. * Sen S . (2000). _Curr. Opin. Oncol._, 12, 82–88. * Sen S, Zhou H and White RA . (1997). _Oncogene_, 14, 2195–2200. * Shibata Y, Haruki N,
Kuwabara Y, Ishiguro H, Shinoda N, Sato A, Kimura M, Koyama H, Toyama T, Nishiwaki T, Kudo J, Terashita Y, Konishi S, Sugiura H and Fujii Y . (2002). _Carcinogenesis_, 23, 1695–1699. *
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP . (1999). _Proc. Natl. Acad. Sci. USA_, 96, 8681–8686. * Tsushimi T, Noshima S, Oga A, Esato K and Sasaki K . (2001).
_Cancer Genet. Cytogenet._, 126, 34–38. * Wang Q, Moyret-Lalle C, Couzon F, Surbiguet-Clippe C, Saurin JC, Lorca T, Navarro C and Puisieux A . (2003). _Oncogene_, 22, 1486–1490. * Wheeler
JM, Beck NE, Kim HC, Tomlinson IP, Mortensen NJ and Bodmer WF . (1999). _Proc. Natl. Acad. Sci. USA_, 96, 10296–10301. * Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR and
Sen S . (1998). _Nat. Genet._, 20, 189–193. Download references ACKNOWLEDGEMENTS We thank T Halazonetis for _Chfr_ constructs. This work was supported by grants from the Comité Départemental
du Rhône and the Comité Départemental de l'Ain de la Ligue de Lutte contre le Cancer, and from the Association pour la Recherche sur le Cancer. AUTHOR INFORMATION AUTHORS AND
AFFILIATIONS * Unité d'Oncologie Moléculaire, INSERM U590, Centre Léon Bérard, 28 rue Laënnec, Lyon, Cedex 08, 69373, France Jacques Bertholon, Qing Wang, Nicole Falette, Carole Verny,
Jessie Auclair, Christelle Chassot, Claudine Navarro & Alain Puisieux * Faculté de Pharmacie, 8 avenue Rockefeller, Lyon, Cedex 08, 69373, France Jacques Bertholon & Alain Puisieux *
Fédération de Spécialités Digestives, Hôpital Edouard Herriot, Place d'Arsonval, Lyon, Cedex 03, 69437, France Jean-Christophe Saurin Authors * Jacques Bertholon View author
publications You can also search for this author inPubMed Google Scholar * Qing Wang View author publications You can also search for this author inPubMed Google Scholar * Nicole Falette
View author publications You can also search for this author inPubMed Google Scholar * Carole Verny View author publications You can also search for this author inPubMed Google Scholar *
Jessie Auclair View author publications You can also search for this author inPubMed Google Scholar * Christelle Chassot View author publications You can also search for this author inPubMed
Google Scholar * Claudine Navarro View author publications You can also search for this author inPubMed Google Scholar * Jean-Christophe Saurin View author publications You can also search
for this author inPubMed Google Scholar * Alain Puisieux View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Alain
Puisieux. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Bertholon, J., Wang, Q., Falette, N. _et al._ _Chfr_ inactivation is not associated to
chromosomal instability in colon cancers. _Oncogene_ 22, 8956–8960 (2003). https://doi.org/10.1038/sj.onc.1207078 Download citation * Received: 20 May 2003 * Revised: 04 August 2003 *
Accepted: 05 August 2003 * Published: 04 December 2003 * Issue Date: 04 December 2003 * DOI: https://doi.org/10.1038/sj.onc.1207078 SHARE THIS ARTICLE Anyone you share the following link
with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt
content-sharing initiative KEYWORDS * _Chfr_ * hypermethylation * chromosome instability * breast cancer * colon cancer